Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000950170-24-111468

Options or other derivatives

  • Director acquired 2,034 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ferrante Karen Jean Director 2024-10-01 Grant or award · Stock Option (Right to Buy) +2,034 2,034 D
Loading xslF345X05/ownership.xml…